SwissNovaGene- Bioresearch- Eurocnda: Scientific Micronutrient Solutions at FIBO 2026
A look back at SwissNovaGene- Bioresearch- Eurocnda at FIBO 2026, showcasing the MOVE line and science-based micronutrient solutions for performance.
SwissNovaGene- Bioresearch- Eurocnda was among the exhibitors at FIBO 2026 and highlighted confirmed topics from the fitness and health market. This recap stays close to the documented material and summarizes what the company showcased this year.
FIBO appearance in review
The appearance focused on confirmed information from the prepared material: topics around MOVE, Move-Stress, and Move-Immunity. The text avoids claims that are not explicitly supported by the prepared exhibitor material.
What SwissNovaGene- Bioresearch- Eurocnda showcased
SwissNovaGene- Bioresearch- Eurocnda presented itself with a clear connection to the fitness and health market. The confirmed focus includes MOVE, Move-Stress, and Move-Immunity.
Relevance for studios and trade audiences
The confirmed topics were especially relevant for visitors interested in Sonstiges (Therapie, Prävention & Rehabilitation), Nahrungsergänzung, and Diätische Produkte. For studios, trainers, and trade audiences, the appearance offered a compact view of the products, brands, and themes SwissNovaGene- Bioresearch- Eurocnda chose to emphasize at FIBO 2026. SwissNovaGene- Bioresearch- Eurocnda exhibited at FIBO 2026 at stand CONE08. Confirmed fair topics in review included MOVE, Move-Stress, and Move-Immunity. Further information about the company and its showcased topics is available at https://www.swissnovagene.com.
Redaktion